Efficacy and safety of orforglipron in type 2 diabetes mellitus and obesity: a GRADE-assessed meta-analysis and trial sequential analysis with subgroup evaluations by diabetic status, obesity status, and dose regimens.

Saved in:
Bibliographic Details
Title: Efficacy and safety of orforglipron in type 2 diabetes mellitus and obesity: a GRADE-assessed meta-analysis and trial sequential analysis with subgroup evaluations by diabetic status, obesity status, and dose regimens.
Authors: Jamal A; Khyber Medical College, Peshawar, Pakistan., Khan S; Khyber Medical College, Peshawar, Pakistan. dr.sulemandawar@gmail.com., Qadri M; Jinnah Sindh Medical University, Karachi, Pakistan., Shah A; Khyber Medical College, Peshawar, Pakistan., Iftikhar H; Khyber Medical College, Peshawar, Pakistan., Fatima E; Allama Iqbal Medical College, Lahore, Pakistan., Ahmad M; Bacha Khan Medical College, Mardan, Pakistan., Sikandar M; Khyber Medical College, Peshawar, Pakistan., Jawed I; Dow Medical College, Karachi, Pakistan., Muneeb M; Khyber Medical College, Peshawar, Pakistan., Mohmand MS; Khyber Medical College, Peshawar, Pakistan., Bacha Z; Khyber Medical College, Peshawar, Pakistan., Khan BW; Khyber Medical College, Peshawar, Pakistan., Jamal T; National Institute of Health, Islamabad, Pakistan., Khalid AA; Peshawar Medical College, Peshawar, Pakistan., Khan MI; Medical University of Sofia, Sofia, Bulgaria., Zulkaif M; Khyber Medical College, Peshawar, Pakistan.
Source: Acta diabetologica [Acta Diabetol] 2026 Apr; Vol. 63 (4), pp. 711-725. Date of Electronic Publication: 2026 Jan 07.
Publication Type: Journal Article; Meta-Analysis; Review
Journal Info: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 9200299 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-5233 (Electronic) Linking ISSN: 09405429 NLM ISO Abbreviation: Acta Diabetol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1432-5233
DOI:10.1007/s00592-025-02635-8